These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 30245242
1. Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer's disease. Brose RD, Lehrmann E, Zhang Y, Reeves RH, Smith KD, Mattson MP. Neurobiol Aging; 2018 Dec; 72():121-133. PubMed ID: 30245242 [Abstract] [Full Text] [Related]
2. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice. Yin K, Jin J, Zhu X, Yu L, Wang S, Qian L, Han L, Xu Y. Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230 [Abstract] [Full Text] [Related]
3. A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits. Aghsami M, Sharifzadeh M, Sepand MR, Yazdankhah M, Seyednejad SA, Pourahmad J. Brain Res Bull; 2018 Jun; 140():34-42. PubMed ID: 29605485 [Abstract] [Full Text] [Related]
4. Protective effects of L-carnitine against beta-amyloid-induced memory impairment and anxiety-like behavior in a rat model of Alzheimer's disease. Tork YJ, Naseri E, Basir HS, Komaki A. Eur J Pharmacol; 2024 Nov 05; 982():176879. PubMed ID: 39128806 [Abstract] [Full Text] [Related]
5. Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms. Fahanik-Babaei J, Baluchnejadmojarad T, Nikbakht F, Roghani M. Metab Brain Dis; 2019 Feb 05; 34(1):191-201. PubMed ID: 30421246 [Abstract] [Full Text] [Related]
6. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease. Zhang X, Zhao F, Wang C, Zhang J, Bai Y, Zhou F, Wang Z, Wu M, Yang W, Guo J, Qi J. Neurosci Bull; 2020 Mar 05; 36(3):254-262. PubMed ID: 31605298 [Abstract] [Full Text] [Related]
7. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons. Chen X, Hu J, Jiang L, Xu S, Zheng B, Wang C, Zhang J, Wei X, Chang L, Wang Q. Neuroscience; 2014 Oct 24; 279():94-101. PubMed ID: 25193238 [Abstract] [Full Text] [Related]
8. Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat model. Elibol B, Beker M, Terzioglu-Usak S, Dalli T, Kilic U. Phytomedicine; 2020 Dec 24; 79():153324. PubMed ID: 32920292 [Abstract] [Full Text] [Related]
9. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice. Liu D, Zhao Y, Qi Y, Gao Y, Tu D, Wang Y, Gao HM, Zhou H. J Neuroinflammation; 2020 Aug 31; 17(1):258. PubMed ID: 32867800 [Abstract] [Full Text] [Related]
10. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease. Huang M, Jiang X, Liang Y, Liu Q, Chen S, Guo Y. Exp Gerontol; 2017 May 31; 91():25-33. PubMed ID: 28223223 [Abstract] [Full Text] [Related]
11. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice. Chen YJ, Zheng HY, Huang XX, Han SX, Zhang DS, Ni JZ, He XY. CNS Neurosci Ther; 2016 Jan 31; 22(1):63-73. PubMed ID: 26584824 [Abstract] [Full Text] [Related]
12. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease. Fragoulis A, Siegl S, Fendt M, Jansen S, Soppa U, Brandenburg LO, Pufe T, Weis J, Wruck CJ. Redox Biol; 2017 Aug 31; 12():843-853. PubMed ID: 28448946 [Abstract] [Full Text] [Related]
13. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Wang X, Hu X, Yang Y, Takata T, Sakurai T. Brain Res; 2016 Jul 15; 1643():1-9. PubMed ID: 27130898 [Abstract] [Full Text] [Related]
14. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA. J Neurosci; 2010 Jun 16; 30(24):8180-9. PubMed ID: 20554868 [Abstract] [Full Text] [Related]
15. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes. Jiang H, Niu F, Zheng Y, Xu Y. Mol Med Rep; 2021 Apr 16; 23(4):. PubMed ID: 33604684 [Abstract] [Full Text] [Related]
16. CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease. Jiao W, Wang Y, Kong L, Ou-Yang T, Meng Q, Fu Q, Hu Z. Biochem Biophys Res Commun; 2018 Jul 02; 501(4):1016-1022. PubMed ID: 29777699 [Abstract] [Full Text] [Related]
17. Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease. Li J, Liu CN, Wei N, Li XD, Liu YY, Yang R, Jia YJ. Brain Res; 2016 Jul 01; 1642():327-335. PubMed ID: 27071547 [Abstract] [Full Text] [Related]
18. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease. Wang ZJ, Zhao F, Wang CF, Zhang XM, Xiao Y, Zhou F, Wu MN, Zhang J, Qi JS, Yang W. J Alzheimers Dis; 2019 Jul 01; 72(4):1217-1231. PubMed ID: 31683484 [Abstract] [Full Text] [Related]
19. Leptin attenuates the detrimental effects of β-amyloid on spatial memory and hippocampal later-phase long term potentiation in rats. Tong JQ, Zhang J, Hao M, Yang J, Han YF, Liu XJ, Shi H, Wu MN, Liu QS, Qi JS. Horm Behav; 2015 Jul 01; 73():125-30. PubMed ID: 26135065 [Abstract] [Full Text] [Related]